06/29/2023
📢 Exciting News! ARDDS (Advanced Robotics Dose Drawing Systems) Unveils Groundbreaking Dose Drawing Robot called IsoDraw-LE at SNMMI 2023 Show in Chicago 🎉
We are thrilled to announce that IsoDraw-LE had an immensely successful debut at the SNMMI 2023 Show in Chicago! The event served as the perfect platform to unveil our revolutionary dose drawing robot for 'Low Energy' radiopharmaceuticals, and the response from attendees was truly remarkable.
ARDDS showcased its game-changing solution for enhanced accuracy and efficiency in radiopharmaceutical dose drawing, leaving a lasting impression on the nuclear medicine community. The SNMMI show provided an excellent opportunity to demonstrate how ARDDS can revolutionize nuclear medicine practice and redefine the standard of care in radiopharmaceutical dosing.
Our dose drawing robot stole the spotlight with its advanced features and capabilities, which include advanced sensors, intelligent algorithms, real-time monitoring, and automated quality control checks. By seamlessly integrating with existing systems such as BioRx and NMIS, IsoDraw-LE streamlines workflows and eliminates manual data entry errors.
We extend our heartfelt gratitude to all the attendees who visited our booth, engaged in insightful discussions, and expressed their enthusiasm for IsoDraw-LE. Your feedback and support have been invaluable in driving us forward. Special thanks to our innovative and transformative thinker and CEO Troy Curnutt, Doug Cluff our fantastic and amazing robotics engineer, Richard Nanney our wonderful programmer, and Justin Curnutt our authorized nuclear pharmacist for coming to the show.
If you missed the chance to witness the power of IsoDraw-LE firsthand at the SNMMI show, don't worry! We invite you to request a demo today to experience how IsoDraw-LE can enhance accuracy and efficiency in nuclear medicine. Let's embark on a journey together towards a future of precise dose drawing, decreased exposure, improved patient outcomes, and streamlined operations.
Stay connected for more exciting updates and advancements in the field of radiopharmaceutical dosing. Together, we will continue to push boundaries and elevate the standards of nuclear medicine practice with IsoDraw-LE. -LE